Corporate Symposia are programs that are planned and conducted by the corporate community in conjunction with the Scientific Sessions. They provide attendees with additional educational opportunities. They will be held at the Hilton New Orleans Riverside in New Orleans, LA. Please note that Corporate Symposia are not part of the official ADA Scientific Sessions program, and that program content and continuing education credit (if applicable) are the sole responsibility of the corporate supporters.
Registration for Corporate Symposia is now open and available to registered attendees of the Scientific Sessions. To participate, log in to your existing registration and add Corporate Symposia or sign up as you complete a new registration for Scientific Sessions.
FRIDAY, JUNE 5, 2026
6:30 p.m.–8:30 p.m.
Pushing the Limits of What Sensing Can Do for T1D and T2D
Sponsored by CMEducation Resources
Supported by an educational grant from Abbott Diabetes Care
6:30 p.m.–7:00 p.m.―Dinner/7:00 p.m–8:30 p.m.―Program)
Using international authorities on diabetes management as faculty, this activity will focus on emerging digital, real time-, and patch-based technologies for continuous monitoring of glucose and ketone levels, to improve drug interventions for diabetes, minimize risks of hypoglycemia and DKA, maximize time in target range for blood glucose, and to optimize treatment interventions and drug titration in across the age spectrum of Type 1 and Type 2 diabetes, including pediatric, adult and elderly persons.
Location: Hilton New Orleans Riverside, Grand Ballroom AB
Contact: Milo Falcon, [email protected]
6:30 p.m.–8:30 p.m.
Patient-centric Obesity Care: From Evidence and Guidelines to Future Directions
Supported by Novo Nordisk A/S
(6:30 p.m.–8:30 p.m.—Program | Light refreshments will be available during the program)
In this symposium, we will review the latest evidence on approved obesity medications and discuss recent developments in obesity guidelines, including updates from ADA. We will also look ahead to emerging therapies that may shape the future of obesity management.
Location: Hilton New Orleans Riverside, Grand Ballroom CD
Contact: Ovgu Kazanc, [email protected]
6:30 p.m.–8:00 p.m.
Obesity: New and Emerging Strategies to Optimally Manage a Chronic Disease
Provided by Physicians Education Resource (PER)
(6:30 p.m.–7:00 p.m.—Registration/7:00 p.m.–8:00 p.m.—Program)
This continuing education (CE) activity will help endocrinologists, diabetes specialists, and other healthcare providers who manage patients with obesity to stay current on the unmet needs in obesity care and how those needs are being addressed. This will include a review of the current guidelines for obesity management, methods for obesity assessment, recommendations for the use of currently approved anti-obesity medications (AOMs), and the current status of emerging agents to potentially expand the therapeutic armamentarium and increase the ability of clinicians to personalize therapy.
Learning Objectives:
- Outline guideline recommended best practices for the management of obesity & associated comorbidities
- Evaluate clinical trial efficacy and safety data for current and emerging therapies for the management of obesity
- Implement recommended procedures to prevent, minimize, or manage AEs associated with AOMs
- Design individualized, comprehensive, guideline-supported AOM-based treatment plans that optimize short- and long-term clinical outcomes while improving HRQoL in patients with obesity
Credit Amount:
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians’ Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hours.
Location: Hilton New Orleans Riverside, St. Charles Ballroom
Contact: Carly Galasso, [email protected]
SATURDAY, JUNE 6, 2026
6:30 a.m.–7:45 a.m.
Glucagon Pharmacology as a Metabolic Signal—A Lightning‑Talk Series
(6:30 a.m.–6:45 a.m.—Breakfast/6:45 a.m.–7:45 a.m.—Program)
Program Description:
Join our esteemed panel, consisting of Deborah Horn, Kirk Habegger, Robert Kushner, Priya Jaisinghani, and Joe Nadglowski, as they discuss ‘Glucagon Pharmacology as a Metabolic Signal’. Through a series of rapid lightning talks, our experts aim to advance scientific and clinical understanding of glucagon’s role in metabolic regulation. Kirk Habegger, as a research scientist, will delve into the current scientific understandings of glucagon’s role in metabolic regulation. Robert Kushner will describe the link between the glucagon signaling and its contribution to systemic metabolism. Priya Jaisinghani will discuss the clinical impact of glucagon biology. Joe Nadglowski will present the patient-centered perspectives on metabolic dysfunction with a personal narrative of navigating obesity. The content is educational in nature and intended for advocates, researchers, and practicing clinicians attending the ADA Scientific Sessions. This is a Boehringer Ingelheim sponsored symposium. Breakfast will be provided.
Agenda Topics:
- Introduction to the Session, Objectives, and Format
Speaker: Deborah Horn - Mechanistic Insights: Glucagon as a Regulator of Metabolism
Speaker: Kirk Habegger - Hormonal Interplay and Metabolic Outcomes: Glucagon in Human Metabolic Disease
Speaker: Robert Kushner - Whole-Body Health: Translating Glucagon Biology into Clinical Phenotypes
Speaker: Priya Jaisinghani - Lived Experience Perspective — A Patient’s Journey
Speaker: Joe Nadglowski - Closing + Q&A
Speaker: All faculty, moderated by Deborah Horn
Speakers and Emails:
- Deborah Horn: [email protected]
- Kirk Habegger: [email protected]
- Robert Kushner: [email protected]
- Priya Jaisinghani: [email protected]
- Joe Nadglowski: [email protected]
Location: Hilton New Orleans Riverside, Grand Ballroom AB
Contact: Lattoya Lartey, [email protected]
5:30 a.m.–7:15 a.m.
Advancing Primary and Endocrinology Care in Chronic Kidney Disease and Heart Failure: Guideline-Based Strategies to Improve Cardiorenal Outcomes
This activity is provided by Med Learning Group
This activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.
(5:30 a.m.–5:45 a.m.—Registration & Breakfast/5:45 a.m.–7:15 a.m.—CE Symposium)
Med Learning Group will conduct an interactive Clinical Conversations Satellite Symposium to enhance clinical decision-making in chronic kidney disease (CKD) and heart failure (HF) that results from cardiorenal metabolic disease (CMD). This 90-minute case-based workshop, led by two expert faculty, will include a patient or caregiver and engage learners through discussion of targeted clinical scenarios.
Who should participate in this educational activity? Primary care providers, including general/family physicians and/or internal medicine physicians; primary care advanced practice providers, including nurse practitioners and physician assistants; and endocrinologists who diagnose and manage patients with CKD and HF due to CMD. Learn about the latest guideline updates, clinical findings, and strategies for shared decision making in collaboration with a multidisciplinary team.
Expert Faculty:
- John E. Anderson, MD
- Yehuda Handelsman, MD, FNLA, FACP, MACE
Location: Hilton New Orleans Riverside, Grand Ballroom CD
Contact: Felecia Beachum, [email protected]
5:30 a.m.–7:45 a.m.
Optimizing T2D Outcomes: A Person-Centered Evolution in Diabetes Care
Supported by Novo Nordisk A/S
(5:30 a.m.–6:15 a.m.—Breakfast/6:15 a.m.–7:45 a.m.—Program)
This symposium will highlight person-centered advances in T2D care, emphasizing holistic management with a focus on cardiometabolic outcomes and weight management. It will review key GLP1 RA trial data and explore recent developments in once weekly basal insulin and its potential use in clinical practice.
Location: Hilton New Orleans Riverside, St. James Ballroom
Contact: Marc Kunkel Winther, [email protected]
5:30 a.m.-7:45 a.m.
Optimizing Body Composition Changes in the Era of Incretin-Based Weight Loss Therapies: The New Frontier
This accredited EC breakfast symposium is jointly provided by The Society on Sarcopenia, Cachexia and Wasting Disorders, Inc. and Partners for Advancing Clinical Education
This activity is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc.
(5:30 a.m.–6:15 a.m.—Breakfast/6:15 a.m.–7:45 a.m.—Program)
Incretin-based therapies enable substantial adiposity reduction but also reduce lean tissue, raising concerns about muscle health. This session examines body composition changes and strategies to optimize body composition during weight loss by preserving or building muscle.
Location: Hilton New Orleans Riverside, St. Charles Ballroom
Contact: Yann Colardelle, [email protected]
6:15 p.m.–8:15 p.m.
Beyond BMI: Transforming Modern Weight Management for Heart, Kidney, and Metabolic Health
Provided by PeerVoice
Supported by an educational grant from AstraZeneca
(6:15 p.m.–6:45 p.m.— Dinner/6:45 p.m.–8:15 p.m.—Program)
In this activity, a multidisciplinary panel of experts integrates an evolving patient case to reframe obesity as a driver of cardiometabolic and renal disease. Faculty will discuss practical, patient-centered strategies for integrating behavioral, nutritional, and pharmacologic interventions–along with coordinated care across specialties–to improve weight management and reduce long-term organ damage.
Chair:
- Carel le Roux, MBChB, MSc, PhD - University College Dublin
Dublin, Ireland
JAZ Chemical Pathologists
London, UK
Presenters:
- Biykem Bozkurt, MD, PhD
Baylor College of Medicine
Houston, Texas, USA - Domenica M. Rubino, MD
Washington Center for Weight Management & Research, Inc.
Arlington, Virginia, USA
Patient Advocate:
- Michael Donnelly-Boylen, MS
Roger Williams University
Boston, Massachusetts, USA
Location: Hilton New Orleans Riverside, Grand Ballroom A
Contact: Maria Clara Luengas, [email protected]
6:15 p.m.–8:00 p.m.
On Track With Chronic Kidney Disease: The Race to Early Detection and Risk Reduction in Type 1 and Type 2 Diabetes
Provided by Medscape Live Meeting Services, LLC
Supported by an educational grant from Bayer US
(6:15 p.m.–6:30 p.m.— Dinner /6:30 p.m.–8:00 p.m.—Program)
Chronic kidney disease (CKD) is a common, underrecognized complication of diabetes that substantially increases cardiovascular risk and worsens long-term outcomes in both type 1 and type 2 diabetes.
Join us for an interactive race-style CME symposium aimed at guiding clinicians through key decision points in early CKD detection, risk stratification, and comprehensive management. Learners will work through evolving patient cases, interpret test results, apply current guideline recommendations, and select evidence-based cardiorenal-protective therapies, with an emphasis on multidisciplinary collaboration to slow CKD progression and reduce CV events.
Register now to stay ahead in diabetes-related CKD care.
Location: Hilton New Orleans Riverside, Grand Ballroom CD
Contact: Grisi Ortega, [email protected]
6:15 p.m.–8:00 p.m.
Shifting the T1D Paradigm: Early Detection, Disease Modification, and Beta Cell Preservation
This activity is provided by Med Learning Group
This activity is supported by an educational grant from Sanofi US
(6:15 p.m.–6:30 p.m.—Registration & Dinner/6:30 p.m.–8:00 p.m.—CE Symposium)
This symposium will provide a practical overview of early detection and disease‑modifying therapies across the type 1 diabetes (T1D) continuum, featuring expert faculty insights alongside a powerful patient perspective. Faculty will discuss current evidence and guidelines for identifying at‑risk individuals, applying therapies that can delay disease progression, as well as exploring emerging strategies to preserve beta cell function in new‑onset T1D.
Key Topics include:
- Evidence‑based approaches to screening and early detection
- Practical considerations for implementing disease‑modifying therapies in presymptomatic T1D
- Emerging strategies to preserve beta cell function in new‑onset T1D
- A patient perspective offering real‑world context on challenges and decision-making
- Interactive, case‑based discussions that translate evidence to practice
Designed to be engaging and clinically relevant, this program equips participants with actionable insights to improve care throughout the T1D continuum.
Expert Faculty:
- Emily K. Sims, MD, MS
- Jay H. Shubrook, DO, FAAFP, FACOFP
Patient Advocate:
- Kimberly Belz, PT, DPT
Location: Hilton New Orleans Riverside, St. James Ballroom
Contact: Felecia Beachum, [email protected]
6:15 p.m.–7:45 p.m.
Breaking the Routine: Modernizing Mealtime Insulin Management in People With Type 1 Diabetes
Provided by Medscape Education
Supported by an educational grant from MannKind Corporation
(6:15 p.m.–6:45 p.m.—Dinner/6:45 p.m.–7:45 p.m.—Program)
Activity Overview:
This program addresses key gaps in clinician knowledge, competence, and confidence related to mealtime insulin therapy. The program reviews pharmacokinetic and pharmacodynamic evidence for modern insulin options—including inhaled human insulin—and explores how these therapies may better align with physiologic insulin needs and patient preferences. Through expert commentary, clinical trial data, and case-based vignettes, learners will examine strategies to overcome adherence barriers such as injection burden, social stigma, and needle fatigue. The activity also highlights practical approaches to integrating inhaled insulin into real-world care, including dosing, titration, and CGM-guided decision-making. Emphasis is placed on shared decision-making and coordinated, multidisciplinary care involving endocrinologists, primary care physicians, NPs/PAs, nurses, and pharmacists to individualize mealtime insulin regimens and improve glycemic outcomes and quality of life for people with diabetes.
Location: Hilton New Orleans Riverside, St. Charles Ballroom
Contact: Tatiana Bruce, [email protected]
SUNDAY, JUNE 7, 2026
6:15 p.m.–8:30 p.m.
Sarcopenia and Diabetes Care: Muscle Health and Targeted Nutrition
Dinner and program supported by an educational grant from Abbott Nutrition
(6:15 p.m.–6:30 p.m.—Doors Open/6:30 p.m.–8:30 p.m.—Dinner & Program)
This symposium will explore the central role of skeletal muscle in metabolic health and diabetes outcomes, highlight evidence for diabetes specific nutrition formulas in improving glycemic control and supporting remission, and provide practical strategies for integrating targeted nutrition and muscle focused care into routine practice.
Location: Hilton New Orleans Riverside, Grand Ballroom AB
Contact: Shaurya Bajpai, [email protected]
6:15 p.m.–8:15 p.m.
The CGM Blueprint: Incorporating Technology to Empower People with Type 2 Diabetes
Provided by Medscape Live Meeting Services, LLC
Supported by an educational grant from Dexcom
(6:15 p.m.–6:45 p.m.—Registration/6:45 p.m.–8:15 p.m.—Program)
Type 2 diabetes (T2D) is a progressive, high-burden disease driving cardiovascular, renal, and metabolic complications despite advances in care.
This symposium reframes real-time continuous glucose monitoring (rtCGM) as a proactive tool for wellness and treatment optimization in T2D, reviewing evidence, implementation strategies, team-based care, CGM metrics, access considerations, and case-based applications to support real-world practice.
Join us to translate evidence into actionable strategies for improving outcomes in T2D.
Location: Hilton New Orleans Riverside, St. Charles Ballroom
Contact: Grisi Ortega, [email protected]